Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-02 · accession 0001209191-21-062788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-03 | 2021-11-02 | PBYI | NOUGUES MAXIMO F | CFO | S - Sale | $5.67 | -156 | 67.4K | -0.2% | -$884.52 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-02 | S | D | 156 | $5.67 | 67,437 | D | — | — |